1. Home
  2. HUCK vs ANTX Comparison

HUCK vs ANTX Comparison

Compare HUCK & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HUCK

Huckleberry.ai Inc. Class B Common Stock

N/A

Current Price

$3.07

Market Cap

159.5M

Sector

Technology

ML Signal

N/A

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

BUY

Current Price

$3.63

Market Cap

172.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
HUCK
ANTX
Founded
2010
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.5M
172.9M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
HUCK
ANTX
Price
$3.07
$3.63
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$4.17
★ $9.00
AVG Volume (30 Days)
★ 763.5K
304.7K
Earning Date
12-03-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
★ 32.56
EPS
N/A
★ N/A
Revenue
★ $318,857,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.33
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 0.57
N/A
52 Week Low
$2.96
$1.00
52 Week High
$3.55
$7.19

Technical Indicators

Market Signals
Indicator
HUCK
ANTX
Relative Strength Index (RSI) 34.64 29.86
Support Level $3.00 $2.87
Resistance Level $3.24 $5.15
Average True Range (ATR) 0.13 0.35
MACD -0.01 -0.08
Stochastic Oscillator 33.90 14.65

Price Performance

Historical Comparison
HUCK
ANTX

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: